首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   127363篇
  免费   7236篇
  国内免费   1136篇
耳鼻咽喉   1951篇
儿科学   1952篇
妇产科学   1874篇
基础医学   20268篇
口腔科学   3087篇
临床医学   11855篇
内科学   22807篇
皮肤病学   3974篇
神经病学   10326篇
特种医学   7378篇
外科学   16643篇
综合类   547篇
现状与发展   3篇
一般理论   27篇
预防医学   6702篇
眼科学   3194篇
药学   11443篇
中国医学   1456篇
肿瘤学   10248篇
  2023年   905篇
  2022年   2715篇
  2021年   4393篇
  2020年   2105篇
  2019年   2944篇
  2018年   3677篇
  2017年   2988篇
  2016年   3900篇
  2015年   5437篇
  2014年   6444篇
  2013年   7510篇
  2012年   11244篇
  2011年   10778篇
  2010年   6187篇
  2009年   5312篇
  2008年   7535篇
  2007年   7185篇
  2006年   6468篇
  2005年   5987篇
  2004年   5217篇
  2003年   4543篇
  2002年   3906篇
  2001年   3037篇
  2000年   2795篇
  1999年   2147篇
  1998年   946篇
  1997年   699篇
  1996年   544篇
  1995年   474篇
  1994年   405篇
  1993年   352篇
  1992年   757篇
  1991年   704篇
  1990年   653篇
  1989年   585篇
  1988年   497篇
  1987年   489篇
  1986年   351篇
  1985年   383篇
  1984年   269篇
  1983年   201篇
  1982年   141篇
  1981年   174篇
  1980年   135篇
  1979年   224篇
  1978年   168篇
  1977年   128篇
  1976年   137篇
  1975年   125篇
  1974年   139篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
BACKGROUND: We studied the economic impact of cytomegalovirus (CMV) disease and its effective reduction with antiviral prophylaxis in liver transplant recipients. METHOD: Analysis of institutional charge data accumulated during a prospective, randomized, controlled trial comparing oral acyclovir 800 mg four times daily for 120 days (ACV) and intravenous ganciclovir 5 mg/kg every 12 h for 14 days followed by ACV for 106 days (GCV) was performed. RESULTS: Liver transplant recipients who developed CMV disease had significantly higher charges (median: $148,300) than those who developed asymptomatic CMV infection ($119,600) or experienced no CMV infection ($114,100) (P<0.01). A multiple linear regression analysis indicated that CMV disease is associated with a 49% increase in charges, independent of other factors influencing increased hospitalization charges. In CMV-seronegative patients who received a CMV-seropositive donor organ, GCV prophylaxis was associated with a significant reduction in charges, as compared to ACV prophylaxis ($113,900 vs. $153,300, respectively; P=0.02). CONCLUSIONS: CMV disease is an independent risk factor for increased resource utilization associated with liver transplantation. The use of an effective prophylactic antiviral regimen provides savings in health care resources, particularly in patients at high risk for developing CMV disease.  相似文献   
994.
995.
996.
Kim WG  Na MH  Kim JH 《Artificial organs》2000,24(9):729-733
An effective in vitro protocol for the investigation of thrombogenicity can provide many advantages in the development of mechanical circulatory assist devices. Strict avoidance of air contact with blood recently was proposed for reliable in vitro evaluation. This study was performed to confirm the necessity of avoidance of air contact for the in vitro test of thrombogenicity in a rotary pump. Two sets of mock circuits with the same rotary blood pumps, reservoirs, and connecting tubes were made. In one system, blood came in contact with air while the other did not. The test blood was heparinized at the dose of 1 IU per 1 ml of blood. The tests were terminated at an activated coagulation time of 1.5 times the control value. The levels of hematocrit, platelet, factors VIII and XII, fibrinogen, thromboxane B2, and plasma-free hemoglobin were measured during the procedures. After the experiments, the thrombi formed were observed, measured, and compared with those formed in in vivo circumstances. The tests were repeated 12 times. There were no statistically significant differences between the 2 groups in hematologic parameters and the amounts of thrombi formed. The thrombi observed in both groups showed the same pathologic findings as those formed in vivo with the exception of intermittent multiple air bubbles found in thrombi of the air-contact group. In conclusion, the effect of air contact in the in vitro investigation of thrombogenicity was negligible while the proposed in vitro test models of thrombogenesis in the mechanical circulatory assist device proved to be reliable.  相似文献   
997.
Jung JS  Lee RH  Koh SH  Kim YK 《Renal failure》2000,22(4):407-421
Ischemic renal injury is associated with defects in transport functions of the proximal tubules and urinary concentration ability. To determine whether alterations in expression of various transporter genes contribute to an impairment in renal functions, the expression of various solute transport genes was analyzed in renal cortex and medulla of rabbits with ischemic acute renal failure. Rabbits were subjected to 60 min of renal pedicle clamping followed by 24, 48, or 72 h of reperfusion. Urine volume and glomerular filtration rate were markedly decreased, which were accompanied by an increase in serum creatinine level and fraction Na+ excretion. Glucosuria and phosphaturia were evident during reperfusion periods. These alterations in renal functions were persisted to 72 h after reperfusion. The Na+-dependent uptakes of glucose and phosphate by brush border membrane vesicles were inhibited by 24 h of reperfusion. mRNA levels for Na+-glucose, Na+-phosphate, and Na+-succinate cotransporter analyzed by RT-PCR were not changed by 60 min of ischemia alone, but were significantly reduced by 24 h of reperfusion. mRNA levels for apical Na+-K+-2Cl- cotransporter, NaCl cotransporter, and turea transporter in the medulla were not changed during reperfusion. Protein levels for AQP2 in the medulla, but not AQP1 in the cortex, analyzed by Western blot were significantly reduced at 24 h after reperfusion. These results suggest that reductions in expression of Na+-cotransporter genes in the proximal tubules may be important factors in the impairment in Na+-dependent reabsorption of solutes and that decrease in AQP2 protein may be involved in defect in urinary concentration ability in rabbits with ischemic acute renal failure.  相似文献   
998.
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号